Cargando…
“Focused Ultrasound-mediated Drug Delivery in Humans – a Path Towards Translation in Neurodegenerative Diseases”
The blood-brain barrier (BBB) has a major protective function in preventing the entry of harmful molecules into the brain, but is simultaneously limiting the delivery of drugs, restricting their potential clinical application in neurodegenerative diseases. Recent preclinical evidence demonstrates th...
Autores principales: | Wasielewska, Joanna M., White, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986691/ https://www.ncbi.nlm.nih.gov/pubmed/35257286 http://dx.doi.org/10.1007/s11095-022-03185-2 |
Ejemplares similares
-
Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2017) -
Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
por: Rodrigues, Gerard A., et al.
Publicado: (2018) -
Antiviral RNAi: Translating Science Towards Therapeutic Success
por: Shah, Priya S., et al.
Publicado: (2011) -
On The Rate and Extent of Drug Delivery to the Brain
por: Hammarlund-Udenaes, Margareta, et al.
Publicado: (2007) -
Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson’s disease
por: Cuomo, Arturo, et al.
Publicado: (2019)